Cell Signaling: Uncovering the secret life of Rho GTPases

New methods to directly visualize Rho GTPases reveal how a protein called RhoGDI regulates the activity of these 'molecular switches' at the plasma membrane.
  1. Jenna A Perry
  2. Amy Shaub Maddox  Is a corresponding author
  1. University of North Carolina at Chapel Hill, United States

Cells are busy places that are constantly responding to a variety of internal and external demands. Molecules that can switch back and forth between two or more states have an important role in helping cells respond to these demands. An important type of molecular switch is the Rho family of GTPases: these proteins cycle between an active form (in which the GTPase is bound to guanosine triphosphate) at the cell membrane and an inactive form (in which it is bound to guanosine diphosphate) that is thought to only be found in the cytoplasm (Figure 1).

The Rho GTPase cycle.

Rho GTPases cycle between active (Rho-GTP; green) and inactive (Rho-GDP; orange) forms: the inactive form is activated (blue arrow) by proteins called GEFs (not shown), and the active form can go on to activate (grey arrow) various downstream effector proteins (grey). Other proteins called GDIs (purple) can bind inactive Rho GTPases and extract them from the membrane (black arrow). Now Golding et al. have shown that GDIs can also bind to active Rho GTPases and extract them from the membrane (purple arrow). Proteins called GAPs (not shown) help convert these active GDI-Rho-GTP complexes into inactive GDI-Rho-GDP complexes (red arrow): this can happen at the membrane or in the cytoplasm. Further research is needed to address a number of questions: can Rho-GTP escape from the GDI-Rho-GTP complex (green arrow)? And how can GEFs activate the Rho-GDP in GDI-Rho-GDP complexes (dashed black arrow)? GEF: guanine nucleotide exchange factor; GDI: Guanine nucleotide dissociation inhibitor; GDP: guanosine diphosphate; GTP: guanosine triphosphate; GAP: GTPase-activating proteins.

Rho GTPases are regulated by a number of other proteins. They are activated by guanine nucleotide exchange factors, and their activity is accelerated by GTPase-activating proteins (Moon and Zheng, 2003; Rossman et al., 2005). Inactive Rho GTPases are chaperoned by a protein called GDI (guanine nucleotide dissociation inhibitor; Garcia-Mata et al., 2011). However, it is not known whether GDI extracts inactive Rho GTPases from the membrane, or how it coordinates with the other proteins that regulate Rho GTPases. These voids in the field exist partly because currently available probes only track active GTPases. Now, in eLife, Adriana Golding and William Bement (University of Wisconsin-Madison) and Ilaria Visco and Peter Bieling (Max Planck Institute of Molecular Physiology) report how they have adapted a strategy previously used to study Rho GTPases in yeast (Bendezú et al., 2015) and employed it to explore how GDI interacts with Rho GTPases in the frog Xenopus laevis and in vitro (Golding et al., 2019).

Golding et al. used two labeling strategies to image two Rho GTPases (Cdc42 and RhoA) in vivo and in vitro. The first strategy consisted of inserting a green fluorescent protein into the middle of the Rho GTPases, so that it would not interfere with the N- or C-termini of the proteins, which are important for activity and localization. In the second approach, they fused a small dye called Cy3 to the proteins. Both of the new tagged versions of Cdc42 and RhoA localized to the correct place and performed their normal roles in the cell.

In wounded X. laevis oocytes, tagged Cdc42 (which allows visualization of both the active and the inactive forms of the protein) did not co-localize completely with the active protein. Rather, it extended slightly past the area marked by an activity reporter, suggesting that inactive Cdc42 associates with the plasma membrane. Gradual overexpression of Abr, a protein that inactivates Cdc42 (Vaughan et al., 2011), caused a dose-dependent decrease of active Cdc42 at the wound site, but had a much milder effect on Cdc42 that had been labeled with Cy3. This suggests that both active and inactive Cdc42 are present at the plasma membrane. GDI localization overlapped with the zones of active Cdc42 and RhoA on the membrane, indicating that GDI is involved in localizing active GTPases. Indeed, GDI overexpression suppressed the activity of both proteins, and reduced the total RhoA and Cdc42 at the membrane. Together, these results suggest that GDI helps shape the zones of active and inactive GTPases on the cell membrane.

These results also suggest that GDI regulates active GTPases by extracting them from the membrane. To test this idea, Golding et al. measured GTPase dissociation from in vitro lipid bilayers. GDI was more efficient at extracting the inactive RhoA and Cdc42 from the lipid bilayer, but was also able to extract active forms of the proteins. Golding et al. even identified a GDI mutant that, despite being able to extract active and inactive RhoA from lipid bilayers, could not extract active Cdc42. This GDI mutant could still extract inactive Cdc42 from the membranes, but with slightly lower efficiency than the wildtype inhibitor. Future work will reveal how perturbing GDI extraction of active Cdc42 affects the cytoskeleton of cells. For example, retaining active Cdc42 specifically is likely to cause an imbalance between the assembly of the cytoskeleton and its ability to contract, driven by RhoA, which would slow down wound closure (Benink and Bement, 2005).

The work of Golding et al. prompts a revision of the canonical GTPase cycle, wherein GDI is no longer a passive shuttle for inactive Rho GTPases, but also extracts active GTPases from the membrane (Figure 1; purple arrow). The results also hint at the possibility that GDIs help to ‘prune’ and concentrate the active GTPase zone. Further studies could investigate how GDIs maintain this zone, which must be localized to perform certain tasks, and therefore must depend on mechanisms that control diffusion (Bement et al., 2006).

This work also inspires other questions. First, does the interaction with GDI at the membrane immediately inactivate or extract active Rho GTPases, or can some Rho GTPases escape and activate more effector proteins (Figure 1; green arrow)? Second, given that GDI appears to have higher affinity for GTPases than the guanine nucleotide exchange factor (Li and Zheng, 1997), it remains to be seen how GDI-bound inactive Rho GTPases become activated (Figure 1, dashed arrow). The answers to these questions and more are within our reach, thanks to the work of Golding, Visco, Bieling and Bement.


Article and author information

Author details

  1. Jenna A Perry

    Jenna A Perry is at the Department of Biology, UNC Chapel Hill, Chapel Hill, United States

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4342-7891
  2. Amy Shaub Maddox

    Amy Shaub Maddox is at the Department of Biology, UNC Chapel Hill, Chapel Hill, United States

    For correspondence
    Competing interests
    No competing interests declared

Publication history

  1. Version of Record published: December 13, 2019 (version 1)


© 2019, Perry and Maddox

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 2,472
    Page views
  • 242
  • 2

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jenna A Perry
  2. Amy Shaub Maddox
Cell Signaling: Uncovering the secret life of Rho GTPases
eLife 8:e53276.

Further reading

    1. Biochemistry and Chemical Biology
    2. Computational and Systems Biology
    Ian R Outhwaite, Sukrit Singh ... Markus A Seeliger
    Research Article

    Kinase inhibitors are successful therapeutics in the treatment of cancers and autoimmune diseases and are useful tools in biomedical research. However, the high sequence and structural conservation of the catalytic kinase domain complicates the development of selective kinase inhibitors. Inhibition of off-target kinases makes it difficult to study the mechanism of inhibitors in biological systems. Current efforts focus on the development of inhibitors with improved selectivity. Here, we present an alternative solution to this problem by combining inhibitors with divergent off-target effects. We develop a multicompound-multitarget scoring (MMS) method that combines inhibitors to maximize target inhibition and to minimize off-target inhibition. Additionally, this framework enables optimization of inhibitor combinations for multiple on-targets. Using MMS with published kinase inhibitor datasets we determine potent inhibitor combinations for target kinases with better selectivity than the most selective single inhibitor and validate the predicted effect and selectivity of inhibitor combinations using in vitro and in cellulo techniques. MMS greatly enhances selectivity in rational multitargeting applications. The MMS framework is generalizable to other non-kinase biological targets where compound selectivity is a challenge and diverse compound libraries are available.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Rui-Qiu Yang, Yong-Hong Chen ... Cheng-Gang Zou
    Research Article Updated

    An imbalance of the gut microbiota, termed dysbiosis, has a substantial impact on host physiology. However, the mechanism by which host deals with gut dysbiosis to maintain fitness remains largely unknown. In Caenorhabditis elegans, Escherichia coli, which is its bacterial diet, proliferates in its intestinal lumen during aging. Here, we demonstrate that progressive intestinal proliferation of E. coli activates the transcription factor DAF-16, which is required for maintenance of longevity and organismal fitness in worms with age. DAF-16 up-regulates two lysozymes lys-7 and lys-8, thus limiting the bacterial accumulation in the gut of worms during aging. During dysbiosis, the levels of indole produced by E. coli are increased in worms. Indole is involved in the activation of DAF-16 by TRPA-1 in neurons of worms. Our finding demonstrates that indole functions as a microbial signal of gut dysbiosis to promote fitness of the host.